Skip to main content

Industry insights

Publications

ATMP reimbursement: A targeted review of global HTA trends

Sarah Coyle, Harry Lewis, Andrew Mumford, Joanne Mumford

Evaluation of the updated French Autorisation d’accès précoce (AAP) Early Access Authorisation pathway

Oliver Darlington, Elise Evers, Sesh Rahim

Reimbursement pathways and associated timelines in European gene therapies

Andrew Mumford, Lorrain Munetsi, Laura Sopeña Alvarez

Innovative contracting schemes for cell and gene therapies in France, Germany, Italy, Spain, and the UK

Andrew Mumford, David Ringger, Laura Sopeña Alvarez

A review of the use of indirect treatment comparisons to support Health Technology Assessments in Ireland

Oliver Darlington, Rachael Piper, Imogen Taylor

Estimating the true cost of weight-based chemotherapy

Janice Cheng, Tom Edmonds, Andrew Mumford, Georgia Roberts

Listen to our podcast: Initiation

Working with Initiate | What to expect working with our market access and health economics consultancy | Initiation Podcast

Developing PROMs in rare diseases | A conversation with Benson Chen from MitoCAMB | Initiation Podcast

Insights from the 2023 Reimbursement Radar wrap-up | Initiation Podcast

View more in Spotify

Events & conferences

We attend a number of major conferences and would love to meet you at the events listed below:

World Orphan Drug Congress US 2025

22nd – 24th April 2025

ISPOR US 2025

13th – 16th May 2025

Talks & webinars

As market access and HEOR experts, we are regularly asked to talk at industry events. We’d love to see you in our audience at the following events:

Life Science Access Academy

Value Based Healthcare for Life Sciences Made Simple

Monday 17th March 13:00 – 14:00 (GMT)